Long acting beta-agonists versus theophylline for maintenance treatment of asthma.

Author: CoughlanJ, GibsonP G, WilsonA J

Paper Details 
Original Abstract of the Article :
BACKGROUND: Theophylline and long acting beta2-agonists are bronchodilators used for the management of persistent asthma symptoms, especially nocturnal asthma. They represent different classes of drug with differing side-effect profiles. OBJECTIVES: To assess the comparative efficacy, safety and si...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1002/14651858.CD001281

データ提供:米国国立医学図書館(NLM)

Long-Acting Beta-Agonists vs. Theophylline for Asthma Maintenance: A Comparative Review

This study, like a desert explorer comparing different routes to reach a distant oasis, examines the comparative effectiveness of long-acting beta-agonists and theophylline for maintaining asthma symptoms. The researchers conducted a review of several randomized controlled trials, analyzing the efficacy and safety of these two classes of medications. The review suggests that long-acting beta-agonists may be more effective and better tolerated than theophylline for asthma maintenance.

Long-Acting Beta-Agonists: A More Effective Option for Asthma Maintenance

This study, like a camel caravan discovering a more efficient path through the desert, highlights the potential of long-acting beta-agonists in managing asthma symptoms. The review found that long-acting beta-agonists may be more effective than theophylline, particularly in reducing night-time symptoms and improving lung function. It's a valuable insight for healthcare providers seeking the most effective and patient-friendly treatment options for their asthma patients.

Asthma Management: Finding the Right Treatment for Each Individual

This review, like a desert oasis offering a variety of resources, emphasizes the importance of finding the right treatment for each individual with asthma. The research highlights the need for a personalized approach, taking into account individual patient needs and preferences. It's a reminder that the journey to managing asthma requires a careful consideration of both clinical effectiveness and individual patient factors.

Dr. Camel's Conclusion

This review provides valuable insights into the comparative effectiveness of long-acting beta-agonists and theophylline for managing asthma. The findings suggest that long-acting beta-agonists may offer a more effective and well-tolerated option for many patients. It's a valuable resource for healthcare providers seeking the most effective and patient-friendly treatment options for their asthma patients.

Date :
  1. Date Completed 2000-07-06
  2. Date Revised 2018-12-21
Further Info :

Pubmed ID

10796631

DOI: Digital Object Identifier

10.1002/14651858.CD001281

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.